NCT00440908 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Reuse of hemodialyzers
American National Standard, Inc./ Association for the Advancement of Medical Instrumentation. ANSI/AAMI RD47, November 7, 2002 [Amended March 21, 2003] Lacson E Jr, Lazarus JM. Dialyzer best practice: single use or reuse? Semin Dial 19:120-128, 2006 Lowrie EG, Li Z, Ofsthun N, Lazarus JM: Reprocessing dialysers for multiple uses: recent analysis of death risks for patients. Nephrol Dial Transplant 19:2823-2830, 2004

A Prospective Observational Cohort Study Tracking Laboratory Markers for Changes Over Time, After Converting Dialyzer Practice From Reuse to Single Use in Outpatient Dialysis Units

Details for clinical trial NCT00440908

Clinical trial NCT00440908 - References